Calcium Acetate/Magnesium Carbonate

醋酸钙/碳酸镁

Report date: 2022/01/14 13:23:58

Base Information

Drug NameCalcium Acetate/Magnesium Carbonate
Drug Alias NameOsvaRen
ClassificationSmall molecules
Mechanisms of ActionPhosphates binders
TargetsPhosphates
Therapy Area/IndicationsHyperphosphatemiaRenal Insufficiency, Chronic
Global Approved IndicationsHyperphosphatemia
Approved Indications in ChinaN/A
Original Approved Country/TerritoryGermany
Original Approved Date2006/07/01
Country/TerritoryGermany
CombinationsYes Calcium acetate
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesFresenius Kabi Ag
China Registration ClassN/A

Develop Information

Active CompaniesFresenius Kabi Ag
Active IndicationsHyperphosphatemia
Inactive IndicationsRenal Insufficiency, Chronic

Other Information

ATC CodeV03AE04
Related LinksN/A